 |
Burns McClellan handles US media for the IPO of Vaccitech, the British biopharmaceutical company that owns the technology behind AstraZeneca’s COVID-19 vaccine.
Vaccitech on April 29 priced the IPO shares at $17 each, which valued the IPO at $579M. The shares trade on the NASDAQ.
Vaccitech was co-founded by University of Oxford scientists Sarah Gilbert and Adrian Hill and has received backing from Google Ventures and Gilead Sciences.
It will receive 1.4 percent of net revenues from the AstraZeneca COVID-19 vaccine, after it is sold for profit following the end of the pandemic, according to the Financial Times.
Founded in 1988 by Lisa Burns, New York-based Burns McClellan bills itself as an independent IR/financial PR firm serving the life sciences market.
It has Ryo Imai and Robeert Flamm working the Vaccitech IPO. London’s Scius Communications (Katja Stout) is working the European media.
C Street Advisory handles iRobot Corp as the marketer of the Roomba autonomous vacuum cleaner files Chapter 11 after being squeezed by cheaper competitors.
Joele Frank represents Confluent Inc. as the Mountain View, CA-based data streaming platform company agrees to be acquired by IBM in a deal with an enterprise value of $11B.
Tom Johnson, who has headed H/Advisors Abernathy since 2016, will join FGS Global as global head of private capital & financial services, effective Dec. 16.
Brunswick Group and Gagnier Communications are handling Paramount’s $30 cash per-share offer for all of Warner Bros Discovery, topping Netflix $27.50 cash/stock transaction.
ICR Inc. handles communications for Enhanced Ltd, which plans to run Olympic-type competitions with athletes using performance-enhancing drugs, as it goes public in a SPAC deal valued at $1.2B via a merger with A Paradise Acquisition Corp. of Hong Kong.
